Establishing Global GMP Compliance with an Enterprise Calibration Management System

Calibration management systems can lead to cost-effective global compliance when coupled with advances in information technology.

External Link - article-40965.pdf

Articles in this issue

over 23 years ago

Article

Regulatory Compliance Training: Who Needs It?

over 23 years ago

Article

E-Validation: A Method for Electronic Validation Protocol Generation, Approval, and Execution

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

PharmTech Weekly Roundup—June 19, 2026

BySusan Haigney

June 19th 2026

First generic of single-dose flu drug approved by the FDA

Why the First Generic Single-Dose Flu Antiviral Approval Matters

ByZachary Zubulake

June 18th 2026

Sustainable eco concept with green globe floating in clear glass beaker symbolizing healthcare and pharma innovation for better future | Image Credit: ©newlifestock -stock.adobe.com

Sustainability by Design: Re-Imagining Amorphous Dispersion Manufacturing

ByElizabeth Hickman

June 18th 2026

Duloxetine recalled over heightend levels of nitrosamine

FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps

ByZachary Zubulake

June 17th 2026

Pharmacovigilance (PV or PhV), also known as drug safety, is the pharmacological science to detection, monitoring, and prevention of adverse effects with pharmaceutical product. Medical safety concept | Image Credit: ©Joel bubble ben -stock.adobe.com

Reimagining Signal Management: How Autonomous Pharmacovigilance Could Render Reporting Timelines a Thing of the Past

ByLucinda Smith

June 16th 2026

Establishing Global GMP Compliance with an Enterprise Calibration Management System

Articles in this issue

Related Content

PharmTech Weekly Roundup—June 19, 2026

Why the First Generic Single-Dose Flu Antiviral Approval Matters

Sustainability by Design: Re-Imagining Amorphous Dispersion Manufacturing

FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps

Reimagining Signal Management: How Autonomous Pharmacovigilance Could Render Reporting Timelines a Thing of the Past

Trending on Pharmaceutical Technology

FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps

Germany Pharma Tariff Threat: What Manufacturers Need to Know

Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next

PharmTech Weekly Roundup—June 19, 2026

Why the First Generic Single-Dose Flu Antiviral Approval Matters